Lista de obras - Daniela Drandi - Dominio Público Uruguay

A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.

artículo científico publicado en 2001

Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations.

artículo científico publicado en 2006

Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma ⬇️

artículo científico publicado el 1 de junio de 2013

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

artículo científico publicado en 2005

Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells.

artículo científico publicado en 2004

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.

artículo científico publicado en 2012

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis

artículo científico publicado en 2017

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.

artículo científico publicado en 2011

High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission

artículo científico publicado en 2006

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia

artículo científico publicado en 2016

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

artículo científico publicado en 2011

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

artículo científico publicado en 2014

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

artículo científico publicado en 2014

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

artículo científico publicado en 2008

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.

artículo científico publicado en 2015

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.

scientific article published on 13 October 2016

Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.

artículo científico publicado en 2011

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.

artículo científico publicado en 2013

PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy.

artículo científico publicado en 2003

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.

artículo científico publicado en 2017

Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma.

artículo científico publicado en 2015

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

publication published on 06 September 2021

Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests

scientific article published on 01 June 2002

Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone.

artículo científico publicado en 2003

Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.

artículo científico publicado en 2006

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

artículo científico publicado en 2017

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.

artículo científico publicado en 2015

Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma

artículo científico publicado en 2021

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

artículo científico publicado en 2004

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients

scientific article published on 15 February 2007

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

artículo científico publicado en 2009

Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.

artículo científico publicado en 2012

Lista de obras de Daniela Drandi

A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.

Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations.

Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma ⬇️

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells.

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.

High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.

Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.

PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy.

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.

Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma.

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests

Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone.

Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.

Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.